DTRT Health Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants Commencing October 25, 2021

Rhea-AI Summary

DTRT Health Acquisition Corp. (NASDAQ: DTRTU) announced that starting October 25, 2021, holders of its 23 million units from the initial public offering can separate their shares of Class A common stock and warrants for individual trading. The separated shares will trade under the symbols DTRT and DTRTW on Nasdaq, while unsplit units will continue under DTRTU. The offering was led by Cantor Fitzgerald and Odeon Capital Group. No fractional warrants will be issued during this process.

Positive

• Facilitates trading flexibility for investors with the separation of shares and warrants.
• Allows investors to engage more dynamically with the underlying assets of DTRT.

Negative

• None.

NEW YORK--(BUSINESS WIRE)-- DTRT Health Acquisition Corp. (NASDAQ: DTRTU) (“DTRT” or the “Company”) announced that, commencing October 25, 2021, holders of the 23,000,000 units sold in the Company’s initial public offering may elect to separately trade the shares of Class A common stock and warrants included in the units. Any units not separated will continue to trade on The Nasdaq Capital Market (the “Nasdaq”) under the symbol “DTRTU,” and the separated shares of Class A common stock and warrants are expected to trade on the Nasdaq under the symbols “DTRT” and “DTRTW,” respectively. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Unitholders will need to have their brokers contact Continental Stock Transfer & Trust Company, the Company’s transfer agent, in order to separate the units into shares of Class A common stock and warrants.

The units were initially offered by the Company in an underwritten offering. Cantor Fitzgerald & Co. (“Cantor”) acted as the sole book-runner and Odeon Capital Group, LLC acted as the lead manager of the offering. A registration statement relating to the units and the underlying securities was declared effective by the Securities and Exchange Commission (the “SEC”) on September 1, 2021.

The offering was made only by means of a prospectus. Copies of the prospectus related to this offering may be obtained by contacting Cantor, Attention: Capital Markets, c/o Cantor Fitzgerald & Co., 499 Park Avenue, 5^th Floor, New York, New York 10022, or by email at prospectus@cantor.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About DTRT

DTRT is a blank check company, also commonly referred to as a special purpose acquisition company, or SPAC, formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. We intend to leverage our team’s expertise to target businesses in the healthcare industry, specifically home and community based healthcare services, which may include home health, personal and private duty care, home-based therapy, adult day care, medical transportation, pediatric health, facility based community services, healthcare information technology and software services, care management, behavioral health, staffing, medical devices, and health and wellness programs, among others.

Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements,” including with respect to the anticipated separation of the units into shares of Class A common stock and warrants. No assurance can be given that the units will be separated as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and final prospectus relating to the Company’s initial public offering filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211022005352/en/

Arion Robbins

arobbins@dtrthealth.com

www.dtrthealth.com

Source: DTRT Health Acquisition Corp.

FAQ

What date can DTRTU shareholders separate their shares?

Holders can separate their shares starting October 25, 2021.

What will the new trading symbols be after the separation?

The separated shares will trade under the symbols DTRT for Class A common stock and DTRTW for warrants.

How many units were offered in DTRT's initial public offering?

DTRT offered 23 million units in its initial public offering.

Who managed the initial public offering for DTRT?

Cantor Fitzgerald acted as the sole book-runner, with Odeon Capital Group as the lead manager.